Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • Request More Information
  • Journalists
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • Request More Information
  • Journalists

Clarivate Expands Real-World Data Offering with Addition of Social Determinant of Health (SDoH) Attributes from HealthWise Data
  • USA - English

Clarivate_Logo

News provided by

Clarivate Plc

31 May, 2024, 12:30 IST

Share this article

Share toX

Share this article

Share toX

Strategic collaboration enhances insight into patient demographics and behaviors, enabling analytical precision in addressing population health outcomes

LONDON, May 31, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced a strategic partnership with HealthWise Data, a leading healthcare data and analytics firm bridging the gap between clinical outcomes and Social Determinants of Health (SDoH) domains. The collaboration integrates SDoH attributes into the Clarivate Real-World Data repository, offering comprehensive patient insights and enabling life science, healthcare and research professionals to enhance patient outcomes and healthcare equity. 

Crucial determinants such as income, education, ethnicity and smoking activity, coupled with unique predictive models around health conscientiousness and lifestyle habits, are known to significantly influence health outcomes and are captured within HealthWise Data's SDoH attributes. Through the partnership with HealthWise Data, these non-medical factors are integrated within the Clarivate Real-World Data Product, providing nuanced insights into patient populations, facilitating targeted interventions and ultimately contributing to enhanced health equity.

Bob Morrison, VP RWD Data Strategy and Operations, Clarivate, said: "As a part of our ongoing commitment to delivering excellence in real world data, our partnership with HealthWise Data represents a significant milestone in our mission to provide clients with connected data and transformative insights. By integrating SDoH attributes into the Clarivate Real-World Data product, we offer payers and providers a comprehensive and unified source of truth, empowering more informed decision-making. This collaboration underscores our joint dedication to driving effective public health interventions and addressing disparities, ultimately fostering improved patient outcomes and advancing healthcare equity."

Anne Smith, CEO, HealthWise Data, said: "We are delighted to engage in a strategic partnership with Clarivate. Layering HealthWise Data's unique SDoH and consumer health and wellness behavioral scores on top of clinical data from Clarivate will provide clients with a more robust view of the patient as a person and improve patient outcomes."

SDoH-enhanced RWD plays a vital role in facilitating public health interventions by identifying populations at heightened risk or that are underserved for specific health concerns, enabling precise and effective early prevention measures. Through a deeper understanding of the influence of social and environmental factors on health outcomes and healthcare accessibility, health systems and providers can engage in collaborative efforts with communities and public health organizations to comprehensively address these factors, reducing health disparities and promoting health equity.

For more information about Clarivate Real-World Data solutions, visit here.

About the Clarivate Integrated RWD Platform

Clarivate's integrated real-world data platform is a comprehensive solution that empowers end users to analyze defined patient cohorts across the entire patient journey. From point of disease populations to treatment outcomes, the solution is enabled through Clarivate's team of leading experts in the Life Sciences industry, as well as its proprietary data curation. This platform is a premier one-stop real-world data solution in the market for servicing all client needs.

About HealthWise Data

HealthWise Data provides a complete view of the Patient-as-a-Person through unique data insights and analytic capabilities. HealthWise Data's universe of 249 million US adults is rich with both social determinants of health (SDOH), and, unique predictions on consumer health behaviors & lifestyles, including likely health adherence, wellness habits, health equity indicators, ability to pay for medical expenses and more, allowing for a holistic view of the individual. Healthcare organizations, analytics firms, marketing agencies and researchers are leveraging HealthWise Data today to drive better targeting for marketing efforts, enhance analytics and reporting, and improve patient outcomes overall. HealthWise Data was founded by Anne F. Smith in 2017. Learn more on HealthWise Data's website or follow on LinkedIn.

About Clarivate
Clarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com

Media Contact:
Catherine Daniel
Director External Communications, Life Sciences & Healthcare, Clarivate
[email protected]

Logo - https://mma.prnewswire.com/media/1159266/Clarivate_Logo.jpg

Modal title

Also from this source

Winbond Selects IPfolio from Clarivate

Winbond Selects IPfolio from Clarivate

Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced that Winbond Electronics Corporation (TSE:...

Clarivate delivers new AI-powered solutions within Innography for competitive benchmarking and standard-essential patent analysis

Clarivate delivers new AI-powered solutions within Innography for competitive benchmarking and standard-essential patent analysis

Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the launch of two new solutions for Innography...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Computer & Electronics

Computer & Electronics

Data Analytics

Data Analytics

Data Analytics

Data Analytics

News Releases in Similar Topics

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.